Factor XI is a plasma glycoprotein that is required for contact vated by human factor XIIa and thrombin in the presence of activation initiated fibrin formation in vitro and for normal dextran sulfate. Murine factor XI differs from human factor hemostasis in vivo. In preparation for developing a mouse XI in that it undergoes autoactivation slowly in the presence model of factor XI deficiency to facilitate investigations into of dextran sulfate. This is due primarily to murine factor XIa this protease's contributions to coagulation, we cloned the preferentially cleaving a site on zymogen factor XI within complementary DNA for murine factor XI, expressed the prothe light chain, rather than the activation site between Arg 371 tein in a mammalian expression system, and compared its and Val
; however, the relevance of these Gaithersburg, MD and Cellgro complete media was from Fisher observations to coagulation in vivo remains to be deterScientific (Pittsburgh, PA). Soy bean trypsin inhibitor (SBTI), lima mined. Furthermore, while it is generally agreed that factor bean trypsin inhibitor (LBTI), and aprotinin were from Sigma ChemXIa contributes to hemostasis by activating factor IX, it is icals, St Louis, MO.
not clear if this step is required for initial thrombin formation
Proteins and reagents for protein purification and Western blots.
or for consolidation of hemostasis after initial formation of Benzamidine, heparin agarose, nitroblue tetrazolium (NBT), and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) were purchased from the fibrin clot through the extrinsic (factor VIIa/tissue factor) Sigma Chemicals. S-sepharose fast flow resin and a Superose-12
pathway.
11-15
chromatography column were from Pharmacia Biotech (Piscataway, An animal model of factor XI deficiency would greatly NJ). Rabbit polyclonal antiserum against human factor XI was raised facilitate investigations into the role of this protein in normal using standard techniques, 20 and IgG was purified from serum by and pathologic coagulation. Although factor XI deficiency staphylococcal protein A chromatography. Purified human factors has been reported in Holstein cattle and sporadically in XIIa, IX, and X were purchased from Enzyme Research Laboratories dogs, 3, 4 there are currently no animal models of factor XI (South Bend, IN) . Human thrombin was prepared as previously de- deficiency that are easily adapted to a laboratory setting.
scribed. 21 Recombinant factor VIII was obtained from Baxter/Hyland
In preparation for developing a murine model of factor XI (Glendale, CA).
deficiency (factor XI ''knockout'' mouse) to address this
Plasmas and reagents for clotting assays. Pooled normal human problem, we have cloned the complementary DNA (cDNA) for murine factor XI and expressed murine and human factor XI in a mammalian cell culture system. The murine and relatively similar enzymatic activities. Unlike human factor plasma, human factor XI, and factor IX-deficient plasmas were from method of Laemmli, 25 followed by staining with Coomassie brilliant blue. Fractions with pure factor XI were pooled and concentrated George King Biomedical (Overland Park, KS). Normal murine plasma in 0.38% sodium citrate was from Pel-Freez Biologicals as above, dialyzed against TBS, and then stored at 070ЊC. Protein concentration was determined by measuring absorbance at 280 nm (Rogers, AK). Thrombosil aPTT reagent was from Ortho Diagnostic (Raratan, NJ).
using an extinction coefficient (1%) for factor XI of 13.1. Plasma assay for factor XI activity. Conditioned serum-free meChromogenic substrates. Substrates S-2366 and S-2765 were from DiaPharma Group (Malmo, Sweden). dia and fractions from purification procedures were screened for factor XI activity by a modified activated partial thromboplastin time Buffers and solutions. 201 SSC is 3.0 mol/L sodium chloride, 0.3 mol/L sodium citrate, pH 7.0. 201 SSPE is 3.0 mol/L sodium (aPTT) assay. Sixty microliters of human factor XI-deficient plasma was mixed with 60 mL of the solution to be assayed and 60 mL of chloride, 0.2 mol/L sodium phosphate monobasic, 20 mmol/L EDTA, pH 7.4. 501 Denhardt's solution is 1% Ficoll (Type 400, Thrombosil aPTT reagent. The mixture was incubated for five minutes at 37ЊC, 60 mL of 25 mmol/L CaCl 2 was added, and the time Pharmacia), 1% polyvinylpyrrolidone, and 1% bovine serum albumin (BSA).
to fibrin clot formation was determined using a Dataclot 2 fibrometer (Helena Laboratories, Beaumont, TX). To determine the specific Miscellaneous reagents. BSA, rabbit brain cephalin, and dextran sulfate (average molecular weight 500,000 daltons) were from Sigma activity of human and murine recombinant factor XI preparations, proteins were diluted to 5 mg/mL in TBS supplemented with 100 Chemicals.
Isolation of the murine factor XI cDNA. A total of 500,000 mg/mL BSA (TBSA) and serial 1:2 dilutions of this stock solution were made in TBSA. Sixty microliters of the stock solution and plaques from the murine liver cDNA library were screened using a full-length human factor XI cDNA probe labeled with 32 P-dATP each serial dilution were tested for factor XI activity as described above. Results were compared with standard curves prepared with using a random hexamer primer method. 22 Two clones (lMFXI-1 and lMFXI-2) that hybridized to this probe were obtained and were pooled normal human or murine plasma. The factor XI concentration of undiluted pooled normal human plasma was considered to reprepurified through two successive plaque purification steps. Sequencing of the cDNA clones was performed using a Sequenase version sent 100% activity (1 U factor XI/mL). Preparations were also tested for factor IX activity by substituting factor IX-deficient plasma for 2.0 DNA sequencing Kit (Amersham Life Sciences, Arlington Heights, IL). The sequence of the murine clones was compared with factor XI-deficient plasma in this assay. Recombinant factor XI preparations did not show factor IX activity. the published cDNA sequences for human factor XI 17 and murine prekallikrein 23 using a MacVector software package (International Preparation and activity of recombinant factor XIa. Purified recombinant murine or human factor XI (100 mg/mL) was suppleBiotechnologies, New Haven, CT).
Expression and purification of recombinant murine and human mented with human factor XIIa (2 mg/mL) and incubated at 37ЊC. Activation was confirmed by demonstrating complete conversion of factor XI. Full-length cDNAs for human and murine factor XI were ligated into the EcoRI cloning site of a mammalian expression vector the single chain zymogen to the two-chain active form on Coomassie Blue-stained SDS-polyacrylamide gels run under reducing condi-(pJVCMV 24 ) containing the cytomegalovirus promoter. Two hundred and ninety-three cells (5 1 10 7 ) were cotransfected with 40 mg of tions. Factor XIIa was neutralized by the addition of corn trypsin inhibitor (CTI) as previously described. 26 Kinetic parameters for the factor XI/pJVCMV and 2 mg of plasmid RSVneo, which contains a gene conferring resistance to neomycin. 24 Transfection was performed cleavage of S-2366 by factor XIa were determined as previously reported. 24 Briefly, 20 mL of factor XIa at 5 mg/mL in TBS with by electroporation using an Electrocell Manipulator 600 (BTX, San Diego, CA). Transfected cells were grown in DMEM with 5% fetal 0.1% BSA (TBSA) was mixed with 75 mL of TBSA and 5 mL of CTI and incubated for 20 minutes at room temperature. The mixture bovine serum and penicillin/streptomycin for 24 hours and then switched to the same medium containing 500 mg/mL of G418. Media was diluted to 900 mL with TBSA and 100 mL of chromogenic substrate S-2366 at varying concentrations (50 to 1,000 mmol/L final was exchanged every 48 hours. G418 resistant clones were transferred to 24-well tissue culture plates on day 10 to 14 of selection, and concentration) was added. Cleavage of S-2366 was followed by measuring the change in absorbance at 405 nm with a Beckman culture supernatants were tested for factor XI activity in a modified activated partial thromboplastin time assay (described below). Clones DU-640 spectrophotometer. Michaelis-Menten constants (K m and Vmax) for the cleavage of the chromogenic substrates were deterexpressing the highest level of recombinant protein were expanded in 2-L roller bottles. After reaching confluence, cells were washed mined by standard methods. The value for Vmax was converted to nanomolar para-nitroanaline (pNA) generated/sec using an extincwith phosphate-buffered saline and 200 mL of Cellgro complete serum free media supplemented with 10 mg/mL SBTI, LBTI, and aprotinin tion coefficient for pNA of 9,800 optical density (OD) units (405 nm)/mol pNA. Turn-over number (k cat ) was calculated from the ratio was added to each roller bottle. Conditioned media was supplemented with benzamidine to 5 mmol/L and stored at 020ЊC.
of Vmax to enzyme concentration. The activation of factor IX by recombinant factor XIa was deterFour liters of conditioned media was dialyzed against 50 mmol/ L sodium acetate, pH 5.2, 250 mmol/L NaCl, 1 mmol/L EDTA and mined by our previously published method. 24 Purified human factor IX (0.05 to 10.0 mmol/L) was incubated with 5 mmol/L CaCl 2 and loaded onto a 100-mL S-sepharose fast-flow cation exchange column. No factor XI activity was detected in the flow through by 0.5 nmol/L factor XIa for 60 seconds at 37ЊC. The reaction was stopped by adding EDTA to a final concentration of 25 mmol/L and clotting assay (described below). The column was eluted with a 1-L linear NaCl gradient (250 to 1,000 mmol/L), and factor XI containing chilling to 4ЊC. The reaction mixture was diluted 1:100 in TBSA and 10 mL of the dilution was mixed with 50 mL of human factor fractions were pooled and dialyzed against 25 mmol/L Tris-HCl, pH 7.4, 100 mmol/L NaCl (Tris-buffered saline [TBS]). Dialysate was VIII (8 U/mL), 10 mmol/L CaCl 2 , rabbit brain cephalin (1:5 dilution of stock) and 10 mL of human thrombin (0.6 U/mL). After incubation loaded onto a 10-mL heparin agarose column equilibrated with TBS and eluted with a 100-mL linear NaCl gradient (100 to 1,000 mmol/ at 37ЊC for 60 seconds to allow the thrombin to activate the factor VIII, 30 mL of human factor X (450 nmol/L) was added and the L). Factor XI containing fractions were pooled and concentrated to a final volume of 500 mL using an Amicon ultrafiltration cell (Amicon, incubation was continued for an additional 5 minutes. The activation of factor X by factor IXa was stopped by adding EDTA to 25 mmol/ Beverly, MA). The preparation was then passed over a Superose-12 gel filtration column and 500 mL fractions were collected. Samples of L final concentration and placing the reaction on ice. Fifty microliters of the reaction was diluted into 490 mL of TBSA, 60 mL of 5 each fraction were run on a 10% polyacrylamide-sodium dodecyl sulfate (SDS) gel under nonreducing conditions according to the mmol/L chromogenic substrate S-2765 was added, and the change AID Blood 0003 / 5h3a$$$$41 07-02-97 18:49:28 blda WBS: Blood
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From in absorbance at 405 nm was followed. The results were compared 2, were hybridized with the human factor XI cDNA probe with a control curve constructed with known concentrations of factor and purified for further analysis. The cDNA inserts of both IXa to determine the extent of factor IX activation by factor XIa.
clones were 2.8 kb in size, and sequencing of the 5 and Michaelis-Menten kinetic parameters were determined using the av-3 ends of the inserts, as well as with an oligonucleotide erage of two sets of experiments for each enzyme.
recognizing a sequence in the human factor XI catalytic
Western blot analysis of activation of factor XI by factor XIIa,
(light chain) domain, confirmed that they were identical. l thrombin, and factor XIa. Recombinant factor XI was diluted to 5 MFXI-1 contained an 1,872-bp open reading frame coding mg/mL in TBS supplemented with 1 mg/mL dextran sulfate (average for a 624 amino acid protein, including an 18 amino acid molecular weight, 500,000 daltons), in the absence or presence of leader peptide (Fig 1) . The amino acid sequence coding for human factor XIIa (2.5 nmol/L), thrombin (2.5 nmol/L), or factor XIa (either murine or human, 5 nmol/L). All reactions were 400 mL mature murine factor XI is 78% homologous to human factor in volume and were incubated at 37ЊC. At various time intervals, XI (Fig 2) and 58% homologous to mouse prekallikrein. 17, 23 30-mL samples were removed and mixed with 10 mL of reducing By comparison, human factor XI and human prekallikrein SDS-sample buffer (500 mmol/L Tris-HCl, pH 6.8, 40% glycerol, are also 58% homologous.
17 lMFXI-1 contained approxi-20% 2-mercaptoethanol, 10% SDS). Samples were run on 10% polymately 140 bp of 5 and 800 bp of 3 untranslated sequence acrylamide-SDS gels, transferred to nitrocellulose membranes using terminating in a polyadenylated tail. with free cystine, and its function is unknown. 27 Otherwise, dATP using the random hexamer primer technique. 22 In addition, the location of the cystine residues are identical in the two the human factor XI cDNA was digested with restriction endonuclespecies indicating that murine and human factor XI share a that murine factor XI is a disulfide-linked dimer (Fig 3A) . factor XI has 50% to 70% of the activity (100 to 140 U/mg) p53 (control) primers were: 5AGAAGTCACAGCACAT-GACof human factor XI when tested in this human plasma system.
GGAGG (upstream primer) and 5TGTTTTTTCTTTTGCGGG-
Recombinant factor XIa. Recombinant murine and hu-GGAGAGG (downstream primer). PCR products were size fractionman factor XIa both appear as two bands when run under ated on a 2.0% agarose gel, stained with ethidium bromide, and reducing conditions on SDS-polyacrylamide gels (Fig 3B) .
photographed.
The heavy chain of the murine molecule appears to be larger RESULTS than its human counterpart. This difference cannot be entirely accounted for by the fact that the murine heavy chain The murine factor XI cDNA. Two clones from the murine liver cDNA library, designated lMFXI-1 and lMFXIis two amino acids longer than the human protein, and may AID be due to differences in glycosylation. The murine light twofold to threefold higher for human factor XIa, mostly attributable to a higher turn-over number (k cat ) for the human chain, which is three amino acids shorter than the human light chain, runs slightly smaller than its human counterpart.
enzyme. The kinetic parameters for the activation of human factor S-2366 (L-pyroglutamyl-prolyl-arginine-p-nitroaniline) is a chromogenic substrate commonly used to measure human IX by human and murine factor XIa are shown in Table 1 . As there is no commercially available chromogenic substrate factor XIa activity. 8, 24 It is also readily cleaved by rabbit factor XIa (D. Gailani, unpublished observation, November for factor IX, a two-stage assay was used in which factor IX is activated by factor XIa in the first step and the resulting 1991). We compared the kinetic parameters of S-2366 cleavage by recombinant human and murine factor XIa (Table 1) .
factor IXa activates factor X in the presence of factor VIIIa and phospholipid in the second step. is then easily determined by chromogenic substrate assay.
24
Activation of murine factor XI by factor XIIa, thrombin, and autoactivation. In purified systems, human factor XI The results of the analysis show that recombinant factor XIa from both species activate human factor IX similarly and is activated slowly by factor XIIa or thrombin in the absence of a negatively charged surface. 8 The rate of these reactions are consistent with our previous data for factor IX activation by human factor XIa using this technique. 24 are markedly increased by polyanions such as dextran sulfate. 7, 8 In addition, dextran sulfate promotes the activation of factor XI by factor XIa (autoactivation). 7, 8 The activation of human factor XI in the presence of dextran sulfate may be followed indirectly by noting the conversion of the 80-kD zymogen to a 45-to 50-kD heavy chain and 35-to 38-kD light chain on western blots of reduced protein. 8 As in the case with the human protein, murine factor XI was slowly activated by either human factor XIIa or thrombin in the absence of a negatively charged surface (data not shown). When murine factor XI is incubated with factor XIIa or thrombin in the presence of dextran sulfate, activation occurs (Fig 4) that is not seen in human factor XI activation under similar conditions (data not shown). The protease responsible for this cleavage could be the factor XIIa or thrombin used to initiate the reaction or the factor XIa subsequently generated. To evaluate the later possibility, murine factor XI was incubated with dextran sulfate and murine factor XIa (Fig 5A) . The result indicates that murine XIa prefers to cleave murine factor XI at a site other than the activation cleavage site, as the fXIc band is generated more rapidly than the heavy chain of factor XIa. The 38-kD band representing the light chain of factor XIa is not seen in this time course, probably because the cleavage that produces fXIc is within the light chain. An approximately 28-kD band (C, for cleavage) is faintly seen and may represent a portion of the cleaved light chain. A similar result was obtained when murine factor XI was incubated with dextran sulfate and human XIa (data not shown) indicating that murine factor XI zymogen differs from human zymogen, which is preferentially cleaved by factor XIa at the activation site between Arg 369 and Ile 370 in the presence of polyanions. 7, 8 The preference for cleavage at a site other than the activation site suggests that zymogen murine factor XI would undergo autoactivation on dextran sulfate slowly, if at all. This is confirmed by the experiment shown in Fig  5B . Figure 5C shows murine factor XIa, before and after the active enzyme makes a proteolytic cleavage within the light chain.
Tissue expression of factor XI messenger RNA. To identify tissues in which factor XI message is expressed, multitissue northern blots containing polyA RNA were initially hybridized with 32 P-labeled full-length factor XI cDNA probes (Fig 6A and B) . Factor XI message is present, as expected, in the liver of both species. Two messages are present in human liver at approximately 2.4 and 4.0 kb, while the mouse message is primarily a single species of 2.8 kb. Surprisingly, 2.4 and 4.0 kb messages were also detected in human pancreas and kidney (Fig 6A) . The 2.4 kb message the nucleotide and amino acid sequences are known only for the human form. 17 Human factor XI consists of a C-terminal trypsin-like catalytic light chain and an N-terminal noncatalytic heavy chain comprised of four repeated 90-91 amino acid subunits called apple domains. 5, 6, 17 Only the highly related protease plasma prekallikrein has been shown to contain similar domains. 18 The murine factor XI cDNA predicts a high degree of sequence homology (78%) with human factor XI, and the two proteins appear to contain identical disulfide bonds and domain structures. A notable difference is the absence of the cystine residue at amino acid position eleven in murine factor XI. Cys 11 in human factor XI forms a disulfide bond with a molecule of free cystine, and its function, if any, is not clear. 27 Meijers et al 32 have reported that this residue may be changed in recombinant factor XI (Cys 321 ) is conserved in the murine cDNA and, indeed, murine factor XI is expressed as a dimer. Factor XI purified from bovine and porcine plasma are also dimeric, however, XI, the human factor XI cDNA was divided into three pieces rabbit factor XI lacks the interchain disulfide bond. [29] [30] [31] The and each was used as a probe for the northern blot. Identical significance of this is not clear and rabbit factor XI may results to those seen in Fig 6A were obtained with probes circulate as a noncovalent dimer. 31 In fact, mutation of Cys 321 representing: (1) the signal peptide and first three apple doin human factor XI to serine does not affect dimer formation, mains, (2) the fourth apple domain and the first 15 amino as other interactions in the fourth apple domain effectively acids of the light chain, and (3) the remainder of the catalytic hold the dimer together. 32 It is not known if factor XI must light chain (data not shown). This indicates that the signals exist as a dimer to be functional in vivo. Recently, we prein human pancreas and kidney are, indeed, factor XI mRNA. pared a factor XI mutant in which the entire fourth apple The human Northern blots were subsequently probed with domain was replaced with the corresponding domain from full-length cDNA probes for the human contact activation prekallikrein (FXI/PKA4). 24 This effectively removes the seproteases, factor XII, and prekallikrein (Fig 6C) . Full-length quences required for dimer formation and results in a monomessage for these proteins was detected only in RNA from meric protein. FXI/PKA4 is activated by factor XIIa, and liver. The signal at approximately 0.8 to 1.0 kb seen for both activated FXI/PKA4 activates factor IX with similar kinetic proteins in the pancreas lane is too small to encode either parameters to those of wild type factor XI.
factor XII or prekallikrein and likely represents a related Human factor XI is activated by factor XIIa, thrombin, and protease species, such as trypsinogen. activated factor XI (autoactivation) on a negatively charged Northern blots are not particularly sensitive assays, and it surface. 5, 7, 8, 14 The amino acid sequence immediately precedis possible that a tissue such as murine pancreas could be ing the activation cleavage site is of interest. Thrombin expressing factor XI mRNA at levels below the detection cleaves many of its substrates immediately after the sequence threshold of the Northern blot. To examine this possibility, X-Pro-Arg (P3-P1 positions, respectively), and this sequence polyA RNA from murine liver and pancreas were reverse is present in both human and murine factor XI. 17 By comparitranscribed, and PCR was performed on the reverse transon, the sequence preceding the factor XIIa cleavage site in scribed material with oligonucletoides that specifically copy murine and human prekallikrein are Asn-Ala-Arg and Sera 600-bp fragment from the murine factor XI cDNA. OligoThr-Arg, respectively. 18,23 These are not typical thrombin nucleotides specific for the murine p53 cDNA were used as cleavage sites, and human prekallikrein is not activated by controls to demonstrate that reverse transcription was sucthrombin. 33 We have prepared a recombinant factor XI molecessful. This technique is several orders of magnitude more cule in which the factor XIIa cleavage site has been changed sensitive than northern blot hybridization. The results of this to that of prekallikrein (manuscript in preparation). This molanalysis (Fig 7) show that factor XI message, while easily ecule is activated normally by factor XIIa, but is not actidetected in murine liver, is not present in murine pancreas.
vated by thrombin confirming the importance of this se-DISCUSSION quence to thrombin mediated cleavage. Like human factor XI, murine factor XI is activated by factor XIIa and thromWe have successfully isolated and expressed a complimentary DNA for murine factor XI and compared the properbin. In contrast, the murine protein undergoes autoactivation AID Blood 0003 / 5h3a$$$$41 07-02-97 18:49:28 blda WBS: Blood
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From poorly on dextran sulfate because murine factor XIa prefers ever, suggest that there are subtle differences in enzymatic properties. Furthermore, there are differences in tissue speto cleave its zymogen at a location other than the activation cleavage site. The physiologic importance of factor XI aucific expression of factor XI mRNA between humans and mice. These findings raise the possibility that factor XI functoactivation is not clear. Factor XII and factor VII bound to tissue factor have been reported to undergo autoactivation, tions in hemostasis differently in the two species, or that the protein may be involved in functions unrelated to hemostasis. and one could postulate that these reactions may be physiologic triggers for contact activation and the extrinsic pathway, respectively. 34 kD protein on platelet membranes, however, the activity 4. Gentry PA: The relationship between factor XI coagulant and factor XI antigen in cattle. Can J Comp Med 48: 58, 1984 has not been completely characterized, and it has not been 5. Bouma BN, Griffin JH: Human blood coagulation factor XI, definitively determined that this protein is a product of the purification, properties, and mechanism of activation by activated factor XI gene. 37 The identification of mRNA for human factor XII. J Biol Chem 252: 6432, 1977 factor XI in organs other than the liver, therefore, is some- 
